cover
Contact Name
Budi Hidayat
Contact Email
jurnal.eki@cheps.or.id
Phone
+6281779151002
Journal Mail Official
jurnal.eki@cheps.or.id
Editorial Address
Department of Health and Policy, Building F Floor 1, Faculty of Public Health Universitas Indonesia, Kampus Baru UI Depok 16424, Depok City, West Java Province, Indonesia
Location
Kota depok,
Jawa barat
INDONESIA
Jurnal Ekonomi Kesehatan Indonesia
Published by Universitas Indonesia
ISSN : 25278878     EISSN : 25983849     DOI : https://doi.org/10.7454/eki
This journal encompasses original research articles, case studies, conceptual fields, review-based studies (very limited, it will be strictly selected), and protocols. The journal publishes research from various topics in health economics, including but is not limited to the following topics: Economic Evaluation Health Financing Health Policy Health Insurance Pharmacoeconomics Health Technology Assessment (HTA) Tobacco Control Jaminan Kesehatan Nasional (JKN) Health and Econometric Article published in Jurnal Ekonomi Kesehatan Indonesia are determined through the blind review process conducted by the editor and reviewers. They provide evaluation and constructive suggestions for the authors. Prior to be accepted, they considers several factors such as whether the manuscript format is in accordance with the manuscript template and writing guidelines for authors, the relevance of the article with scopes, and its contribution to the development of health economics evaluation and accounting practices as well as the health policy.
Articles 6 Documents
Search results for , issue "Vol. 2, No. 2" : 6 Documents clear
Analisis Praktik Koordinasi Manfaat (Coordination of Benefit) Layanan Rawat Inap di Indonesia Dewi, Fera Mutiara; Hidayat, Budi
Jurnal Ekonomi Kesehatan Indonesia Vol. 2, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Nowadays, some people may have double insurance. Besides having compulsory insurance that regulated by government, they also have additional health insurance which is not mandatory. This condition has opened up opportunities for Coordination of Benefit (COB) in Indonesia, especially in JKN era. Unfortunately, in practice COB still not executed according to the principle of general rules of insurance. This research seeks to analyze the practice of the COB and COB fee scale in Indonesia. The method used is the observational study with cross sectional design. The modeling uses an econometric approach that is a two-part model which separates the process between the COB practice and the COB funds. The result of the research states that age covariate, LOS, and circulatory system diseases show significant effects in statistical testing. Lack of coordination between providers and assurer or between assurer and assurer, causes increasing potential moral hazard by both participants and providers so that participants may get double coverage. The suggestions of this research are first the need to create an independent organization that manages COB and second the need to made regulation of COB.
Analisis Perbandingan Biaya Langsung (Direct Cost) dan Biaya Tidak Langsung (Indirect Cost) pada Pasien Stroke Di Rumah Sakit Aulia, Destanul; Ayu, Sri Fajar; Ritonga, Nefonafratilova
Jurnal Ekonomi Kesehatan Indonesia Vol. 2, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Stroke is divided into two categories, ischemic and hemorrhagic. Each year there are 15 million people around the world who suffer a stroke. Stroke treatment requires a high cost. The burden of heart disease and stroke from 2012 to 2030 reaches Rp. 1,7 trillion. This study aimed to analyze the comparison of direct and indirect costs of stroke patient in X hospital in 2017. The results showed that the number of ischemic stroke patients more than hemorrhagic stroke patients. The average cost of hemorrhagic stroke patients is greater at Rp 3,763,750 than the average cost of ischemic stroke patients. The total direct cost of stroke patients is Rp. 527,895,000 (54.7%) and the total indirect cost of Rp. 437,295,000 (45.3%). It is recommended that the public more actively to monitor health, blood pressure movements, and symptoms of stroke.
Determinan Variasi Klaim Penyakit Stroke Peserta Jaminan Kesehatan Nasional Rumah Sakit X Sumatera Utara Mahulae, Joan Xaveria; Ilyas, Jaslis
Jurnal Ekonomi Kesehatan Indonesia Vol. 2, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Refers to IHME study in 2010 about Global Burden of Disease shows that stroke is one of the highest cause of mortality in Indonesia. While the expenditure by BPJS Health for stroke is the 2nd highest after heart disease. This study aims to determine the most dominant characteristics associated with the total claims of stroke patients covered by JKN for inpatient service at X Hospital by doing multivariate analysis with variable linear regression method. The most significant characteristics are type of health care, type of membership, length of stay age, and level of severity. The finding shows that X Hospital is still not optimal in providing services for stroke. Some feasible efforts that can be considered are increasing the neurovascular experts and providing better diagnostic equipments in order to deliver the necessary treatment.
Cost of Treatment Demam Berdarah Dengue (DBD) di Rawat Inap Berdasarkan Clinical Pathway di RS X Jakarta Rejeki, Vera Marietha Meinar; Nurwahyuni, Atik
Jurnal Ekonomi Kesehatan Indonesia Vol. 2, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Hospitals as health care providers are now required to perform cost and quality control without neglecting the quality of services. Clinical pathways which underlying quality and cost control in the hospital are available but has not been audited. This study aims to determine the unit cost of services in RS X Jakarta, the utilization of hospital services for dengue disease and cost of treatment of DHF in RS X Jakarta. A cross-sectional study was performed in this study. A quantitative approach was done through data collection from hospital information system, medical record and financial data. The result showed that there was a gap between the cost of treatment of DHF patients which based on the clinical pathway (2,184,588 IDR) and the cost of treatment based on the real condition (2,382,512 IDR). The biggest difference between cost of treatment and real cost was in the hospitalization cost and medicine cost. Cost of treatment without salary and investation calculation for DHF patients can be reduced significantly by 29%. Cost of treatment without salary calculation for DHF patients can be reduced significantly by 42%. There is a need for monitoring system and the establishment of hospital case mix team in order to optimize the hospital clinical pathway in the JKN era.
Timbang Besarnya Manfaat dari Salah Sasar Penerima Bantuan Iuran Jaminan Kesehatan Soewondo, Prastuti
Jurnal Ekonomi Kesehatan Indonesia Vol. 2, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

One of the foremost government policies implemented in achieving Universal Health Coverage for the Indonesian population is the provision of financial assistance through contribution of Social Health Insurance for 92.4 million targeted poor and near poor households. This segment of the population is referred to as Penerima Bantuan Iuran (PBI) and represents about 35% of the total population. This study reveals the government’s progress in protecting the health of this sub-population. The data is derived from the 2016 National Social Economic Survey. The results indicate that, at the national level, the government’s health protection program has reached the majority of poor and near poor household (51%), especially those residing in Eastern part of the country (58%). Together with local government’s support, 59.5% of poor and near poor households (66.4% in Eastern region) have been insured. While improvements in coverage should still be top policy agenda, this achievement of the government deserves more appreciation. We show that misallocation of PBI to wealthy households is only small (3%), yet often broadcasted with much hype to create agitation
Perkembangan Asuransi Kesehatan Swasta di Indonesia Tahun 2012-2016 Sari, Kurnia
Jurnal Ekonomi Kesehatan Indonesia Vol. 2, No. 2
Publisher : UI Scholars Hub

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Total private insurance spending in 2015 is about 3.9% of Indonesia’s health expenditures. Although it is not considerably high, the information about private health insurance in Indonesia is still limited. This review is aimed to provide an overview of the private health insurance company growths in Indonesia. The number of private insurance company does not grow significantly, while the number of membership tends to fluctuate in the last 5 years, even it is tend to decrease for non life insurance category. Sums assured tend to rise until 2014, then stagnant for the next period. The amount of premium received by the company and claims to be paid (claim ratio) is considerably increase. It could not be denied that government program for achieving the universal health coverage is a threat to private insurance

Page 1 of 1 | Total Record : 6